184 related articles for article (PubMed ID: 2119437)
1. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck.
Wolf GT; Carey TE; Schmaltz SP; McClatchey KD; Poore J; Glaser L; Hayashida DJ; Hsu S
J Natl Cancer Inst; 1990 Oct; 82(19):1566-72. PubMed ID: 2119437
[TBL] [Abstract][Full Text] [Related]
2. Expression of A9 antigen and loss of blood group antigens as determinants of survival in patients with head and neck squamous carcinoma.
Carey TE; Wolf GT; Hsu S; Poore J; Peterson K; McClatchey KD
Otolaryngol Head Neck Surg; 1987 Mar; 96(3):221-30. PubMed ID: 3108804
[TBL] [Abstract][Full Text] [Related]
3. Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.
Wolf GT; Carey TE
J Natl Cancer Inst Monogr; 1992; (13):67-74. PubMed ID: 1389697
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the A9 antigen/alpha 6 beta 4 integrin in head and neck cancer.
Van Waes C; Carey TE
Otolaryngol Clin North Am; 1992 Oct; 25(5):1117-39. PubMed ID: 1383908
[TBL] [Abstract][Full Text] [Related]
5. The A9 antigen associated with aggressive human squamous carcinoma is structurally and functionally similar to the newly defined integrin alpha 6 beta 4.
Van Waes C; Kozarsky KF; Warren AB; Kidd L; Paugh D; Liebert M; Carey TE
Cancer Res; 1991 May; 51(9):2395-402. PubMed ID: 1750876
[TBL] [Abstract][Full Text] [Related]
6. Altered expression in squamous carcinoma cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9.
Kimmel KA; Carey TE
Cancer Res; 1986 Jul; 46(7):3614-23. PubMed ID: 3708592
[TBL] [Abstract][Full Text] [Related]
7. Expression of cancer/testis (CT) antigens in squamous cell carcinoma of the head and neck: evaluation as markers of squamous dysplasia.
Piotti KC; Scognamiglio T; Chiu R; Chen YT
Pathol Res Pract; 2013 Nov; 209(11):721-6. PubMed ID: 24011616
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant.
Kimmel KA; Carey TE; Judd WJ; McClatchey KD
J Natl Cancer Inst; 1986 Jan; 76(1):9-19. PubMed ID: 2416979
[TBL] [Abstract][Full Text] [Related]
9. 11p deletions and breakpoints in squamous cell carcinoma: association with altered reactivity with the UM-E7 antibody.
Bradford CR; Kimmel KA; Van Dyke DL; Worsham MJ; Tilley BJ; Burk D; del Rosario F; Lutz S; Tooley R; Hayashida DJ
Genes Chromosomes Cancer; 1991 Jul; 3(4):272-82. PubMed ID: 1958593
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical examination of 11 cell lines derived from human head and neck squamous cell carcinomas, their recurrences or metastases.
Koldovsky P; Haas I; Bier H; Ganzer U
Eur Arch Otorhinolaryngol; 1995; 252(6):359-65. PubMed ID: 8679156
[TBL] [Abstract][Full Text] [Related]
11. 44-kd oncofetal transplantation antigen in rodent and human fetal cells. Implications of recrudescence in human and rodent cancers.
Coggin JH; Rohrer SD; Hester RD; Barsoum AL; Rashid HU; Gussack GS
Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1257-66. PubMed ID: 8217085
[TBL] [Abstract][Full Text] [Related]
12. Blood group antigens and integrins as biomarkers in head and neck cancer: is aberrant tyrosine phosphorylation the cause of altered alpha 6 beta 4 integrin expression?
Carey TE; Nair TS; Chern C; Liebert M; Grossman HB; Wolf GT; Van Waes C
J Cell Biochem Suppl; 1993; 17F():223-32. PubMed ID: 8412198
[TBL] [Abstract][Full Text] [Related]
13. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker.
Shin DM; Voravud N; Ro JY; Lee JS; Hong WK; Hittelman WN
J Natl Cancer Inst; 1993 Jun; 85(12):971-8. PubMed ID: 8098774
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B.
Carey TE; Van Dyke DL; Worsham MJ; Bradford CR; Babu VR; Schwartz DR; Hsu S; Baker SR
Cancer Res; 1989 Nov; 49(21):6098-107. PubMed ID: 2790823
[TBL] [Abstract][Full Text] [Related]
15. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
16. The monoclonal antibody BQ16 identifies the alpha 6 beta 4 integrin on bladder cancer.
Liebert M; Wedemeyer G; Stein JA; Washington RW; Van Waes C; Carey TE; Grossman HB
Hybridoma; 1993 Feb; 12(1):67-80. PubMed ID: 8454305
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunodiagnosis of human-derived squamous cell carcinoma.
Wahl RL; Kimmel KA; Beierwaltes WH; Carey TE
Hybridoma; 1987 Apr; 6(2):111-9. PubMed ID: 3570303
[TBL] [Abstract][Full Text] [Related]
19. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
[TBL] [Abstract][Full Text] [Related]
20. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
